Dutton Associates Featured Company: IR Biosciences Holdings, Inc (IRBS.OB)
IR BioSciences Holdings, Inc. is a development-stage biotechnology company engaged in the research and development of potential drug candidates like Homspera™ and its derivatives, Radilex® and Viprovex®. Its goals include developing these potential drug candidates for use as possible countermeasures for homeland security threats including radiological, chemical and biological agents. In addition, the company believes that these products will also meet various commercial needs such as in radiation therapy, or cures for influenza, anthrax and other microbial ailments. The company has discovered that certain attributes of Homspera may potentially open additional commercialization opportunities in areas such as human adult stem…